Patent · US Active

Recombinant anti-MUC1 antibodies

US9546217B2 · kind B2 · utility

2Cited by

0References

15Claims

0Family size

Assignee

MAB FACTORY GMBH · DE

Inventors

Christian Behrens · Palaiseau, FR
Holger Thie · Biberach, DE
Michael Hust · Hannover, DE
Lars Toleikis · Kleinniedesheim, DE
Thomas Schirrmann · Berlin, DE
Stefan Dubel · Dossenheim, DE
Christophe De Romeuf · Lille, FR

Key dates

Filing date	Jul 17, 2009
Grant date	Jan 17, 2017
Priority date	—
Expiry date	Oct 17, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Antibodies having a high specificity and high affinity towards the human gene product MUC1, which in specific variants is associated with neoplastic cells, i.e. tumor tissue, to the use of the antibodies for medical purposes, i.e. for tumor treatment, and for analytical purposes, e.g. for tumor diagnosis. Compositions comprising the antibodies, e.g. for use in the analytical processes and analysis, to pharmaceutical compositions comprising the antibodies, and to use of the antibodies in the manufacture of pharmaceutical compositions for tumor treatment or for diagnostic purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.